Skip to main content
Livermore
Livermore
ZHEN

Northern Trust Corp

SEC CIK
0000073124
Latest filing
Aug 13, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Northern Trust Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RAPT by Northern Trust Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−40,504−100.0%Sold outHolders
Q4 202540,504$1.37M<0.1%+23,484+138.0%AddedHolders
Q3 202517,020$438.9K<0.1%−7,719−31.2%ReducedHolders
Q2 202524,739$197.9K<0.1%−343,466−93.3%ReducedHolders
Q1 2025368,205$449.2K<0.1%+122,606+49.9%AddedHolders
Q4 2024245,599$388.0K<0.1%+3,098+1.3%AddedHolders
Q3 2024242,501$487.4K<0.1%−32,662−11.9%ReducedHolders
Q2 2024275,163$839.2K<0.1%−21,290−7.2%ReducedHolders
Q1 2024296,453$2.66M<0.1%−8,534−2.8%ReducedHolders
Q4 2023304,987$7.58M<0.1%+7,292+2.4%AddedHolders
Q3 2023297,695$4.95M<0.1%+10,142+3.5%AddedHolders
Q2 2023287,553$5.38M<0.1%+979+0.3%AddedHolders
Q1 2023286,574$5.26M<0.1%+35,383+14.1%AddedHolders
Q4 2022251,191$4.97M<0.1%+2,695+1.1%AddedHolders
Q3 2022248,496$5.98M<0.1%+3,025+1.2%AddedHolders
Q2 2022245,471$4.48M<0.1%+33,442+15.8%AddedHolders
Q1 2022212,029$4.66M<0.1%−2,667−1.2%ReducedHolders
Q4 2021214,696$7.88M<0.1%−2,502−1.2%ReducedHolders
Q3 2021217,198$6.75M<0.1%+31,505+17.0%AddedHolders
Q2 2021185,693$5.90M<0.1%+49,270+36.1%AddedHolders
Q1 2021136,423$3.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.